FDA 483 - Prasad Padala, M.D. - November 18, 2021

The FDA inspected Prasad Padala, M.D., a clinical investigator in Little Rock, AR, from November 15-18, 2021. A single observation was noted, concerning a failure to conduct an investigation in accordance with the investigational plan. Specifically, a protocol deviation for subject diary compliance was not reported.